Affymax is a bio-pharmaceutical company
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2013 | AFFYMAX, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination (No Activity) |
— | — | |
| 2012 | AFFYMAX, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | — | |
| 2012 | AFFYMAX, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | — | |
| 2012 | AFFYMAX, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report (No Activity) |
— | — | |
| 2012 | AFFYMAX, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | — | |
| 2011 | AFFYMAX, INC. |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— | — | |
| 2011 | AFFYMAX, INC. |
4th Quarter (Oct 1 - Dec 31) Registration |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| AFFYMAX, INC. | 7 | — |
| Name | Disclosed Prior Position |
|---|---|
| PAUL SMEDBERG |